Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice. (Q43823409)
Jump to navigation
Jump to search
scientific article published in December 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice. |
scientific article published in December 2001 |
Statements
Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice (English)
P Somma
A Casini
I Andreini
F Sarlo
M Condorelli
1 December 2001
107-15; discusssion 115-6